Eyenovia, Inc. Banner Image

Eyenovia, Inc. has reached its limit for free report views

Work for Eyenovia, Inc.? Upgrade Your Profile and unlock all your annual reports.

Eyenovia, Inc.

  • Ticker EYEN
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Eyenovia, Inc. Logo Image
  • 11-50 Employees
  • Based in New York City, New York
Eyenovia, Inc. (NASDAQ: EYEN) is a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose array print (MAP™) therapeutics. Eyenovia’s pipeline is currently focused on the late-stage development of microdosed medications for presbyopia, myopia progression and mydriasis.
Eyenovia, Inc.

Most Recent Annual Report

Eyenovia, Inc. MOST RECENT 2019 Annual Report and Form 10K

Report Locked. Eyenovia, Inc. has reached its limit for free report views.

Older/Archived Annual Reports